Table 4. Risk factors for developing... | American Society of Hematology

Table 4.

Risk factors for developing LONIPCs

	All patients			LONIPC patients
Factor	n	%	n	%	P
Sex: male vs female	52 of 76	68.4	12 of 18	66.7	NS
Source
Related PBSCs vs BM	18 of 27	66.7	6 of 7	85.7	NS
Unrelated BM vs related BM	47 of 56	83.9	11 of 12	91.7	NS
HLA compatibility: mismatch vs full match	17 of 76	22.4	4 of 18	22.2	NS
Blood type mismatch: + vs −	28 of 76	36.8	5 of 18	27.8	NS
Sex mismatch: + vs −	29 of 76	38.2	7 of 18	38.9	NS
Conditioning: TBI/TLI vs non-TBI/TLI	35 of 76	46.1	11 of 18	61.1	NS
GVHD prophylaxis: CsA vs FK506	60 of 76	78.9	16 of 18	88.9	NS
Acute GVHD: II-IV vs 0/I	29 of 76	38.2	8 of 18	44.4	NS
Chronic GVHD: extensive vs 0/limited	37 of 76	48.7	15 of 18	83.3	.0008
Liver: + vs −	32 of 76	42.1	9 of 18	50.0	NS
Skin: + vs −	35 of 76	46.1	10 of 18	55.6	NS
Sicca syndrome: + vs −	33 of 76	43.4	15 of 18	83.3	<.0001
Disease status: high vs standard	38 of 69	55.1	14 of 17	82.4	.0092

	All patients			LONIPC patients
Factor	n	%	n	%	P
Sex: male vs female	52 of 76	68.4	12 of 18	66.7	NS
Source
Related PBSCs vs BM	18 of 27	66.7	6 of 7	85.7	NS
Unrelated BM vs related BM	47 of 56	83.9	11 of 12	91.7	NS
HLA compatibility: mismatch vs full match	17 of 76	22.4	4 of 18	22.2	NS
Blood type mismatch: + vs −	28 of 76	36.8	5 of 18	27.8	NS
Sex mismatch: + vs −	29 of 76	38.2	7 of 18	38.9	NS
Conditioning: TBI/TLI vs non-TBI/TLI	35 of 76	46.1	11 of 18	61.1	NS
GVHD prophylaxis: CsA vs FK506	60 of 76	78.9	16 of 18	88.9	NS
Acute GVHD: II-IV vs 0/I	29 of 76	38.2	8 of 18	44.4	NS
Chronic GVHD: extensive vs 0/limited	37 of 76	48.7	15 of 18	83.3	.0008
Liver: + vs −	32 of 76	42.1	9 of 18	50.0	NS
Skin: + vs −	35 of 76	46.1	10 of 18	55.6	NS
Sicca syndrome: + vs −	33 of 76	43.4	15 of 18	83.3	<.0001
Disease status: high vs standard	38 of 69	55.1	14 of 17	82.4	.0092

NS indicates not significant.